Shenzhen Mindray Bio-Medical Electronics revenue and financials
¥161.32Change from previous close: +1.45%Absolute change: +¥2.31
In the fiscal year ended December 2025, Shenzhen Mindray Bio-Medical Electronics reported revenue of ¥33.28B (−9.38% year over year). Net income was ¥8.14B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −9.38%
- 2025 vs 2024
- Net income growth
- −30.28%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 31.8%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total assets | 60,787 | 59,615 | 59,267 | 58,775 | 58,365 |
| Current assets | 29,337 | 28,054 | 27,410 | 27,179 | 27,310 |
| Cash and equivalents | 18,699 | 17,793 | 17,690 | 16,967 | 17,711 |
| Short-term investments | 75.6 | 296 | 250 | 122 | — |
| Inventory | 5,650 | 5,254 | 5,004 | 5,344 | 5,173 |
| Net property, plant and equipment | 11,565 | 11,414 | 11,150 | 10,520 | 10,132 |
| Goodwill | 11,112 | 11,207 | 11,404 | 11,506 | 11,220 |
| Other intangible assets | 6,402 | 6,508 | 6,671 | 6,922 | 6,976 |
| Long-term investments | 196 | 189 | 180 | 169 | 165 |
| Current liabilities | 12,445 | 11,745 | 11,600 | 10,605 | 10,741 |
| Accounts payable | 4,039 | 3,545 | 3,242 | 3,478 | 3,134 |
| Long-term debt | 0.2 | 0.3 | 4.1 | 4.2 | 0.3 |
| Total debt | 311 | 343 | 349 | 333 | 300 |
| Total liabilities | 15,484 | 14,769 | 16,255 | 14,753 | 14,807 |
| Total equity (incl. minority) | 45,303 | 44,846 | 43,011 | 44,021 | 43,558 |
| Retained earnings | 33,048 | 32,471 | 30,143 | 30,301 | 30,248 |
| Minority interest | 4,746 | 4,735 | 4,918 | 4,981 | 4,968 |